Clinical Trial Update: Apidra Children & Adolescents Study [Phase 4]

View source ↗

Summary

Phase 4 trial update for Apidra in children and adolescents completed; study examines insulin glulisine in Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Apidra (insulin glulisine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED